Drug Trial Radar · NCT00441727
Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)
Last checked: Nov 20, 2026Latest source record: Jul 16, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,426
Actual
Start
Feb 2007
Primary completion
Aug 2008
Study completion Aug 2008
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Mar 1, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effect of esomeprazole 20 or 40 mg once daily versus placebo on the occurrence of peptic ulcers during 26 weeks in subjects on continuous low-dose acetylsalicylic acid.
Conditions
- Gastric Ulcer
- Duodenal Ulcer
Interventions
Esomeprazole 40 mgDrug
Esomeprazole 40 mg once daily
Esomeprazole 20 mgDrug
Esomeprazole 20 mg once daily
PlaceboDrug
Placebo once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Experienced the Occurence of Peptic Ulcer(s).Time frame: During 26 weeks
Locations
189 sites in 20 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Tucson, Arizona
Research Site
Anaheim, California
Research Site
Lancaster, California
Research Site
Los Angeles, California
Research Site
Orange, California
Research Site
San Carlos, California
Research Site
San Diego, California
Research Site
Torrington, Connecticut
Research Site
Boynton Beach, Florida
Research Site
Hollywood, Florida
Research Site
Jacksonville, Florida
Research Site
Jupiter, Florida
Research Site
Miami, Florida
Research Site
New Smyrna Beach, Florida
Research Site
Pembroke Pines, Florida
Research Site
Plantation, Florida
Research Site
South Miami, Florida
Research Site
Tampa, Florida
Research Site
Zephyrhills, Florida
Research Site
Fulton, Illinois
Research Site
Wichita, Kansas
Research Site
Shreveport, Louisiana
Research Site
Baltimore, Maryland
Research Site
Hollywood, Maryland
Research Site
Prince Frederick, Maryland
Research Site
Brockton, Massachusetts
Research Site
Jackson, Mississippi
Research Site
Las Vegas, Nevada
Research Site
Egg Harbor, New Jersey
Research Site
Albuquerque, New Mexico
Research Site
Great Neck, New York
Research Site
Fayetteville, North Carolina
Research Site
Greensboro, North Carolina
Research Site
Jacksonville, North Carolina
Research Site
Winston-Salem, North Carolina
Research Site
Centerville, Ohio
Research Site
Cincinnati, Ohio
Research Site
Dayton, Ohio
Research Site
Guthrie, Oklahoma
Showing 40 of 189 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.